A short synthesis of argatroban: a potent selective thrombin inhibitor

This publication has 14 references indexed in Scilit:

• Direct diastereoselective synthesis of (±)-cis- and (±)-trans-4-methylpipecolic acid and derivatives
  Tetrahedron Letters, 2001
• Bronchoconstrictor effect of thrombin and thrombin receptor activating peptide in guinea‐pigs in vivo
  British Journal of Pharmacology, 1999
• Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty.
  Circulation, 1993
• Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile
  Trends in Pharmacological Sciences, 1993
• Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty.
  Circulation, 1993
• A Strategy for a Rational Approach to Designing Synthetic Selective Inhibitors
  Seminars in Thrombosis and Hemostasis, 1992
• Argatroban, A Selective, Potent Thrombin Inhibitor
  Cardiovascular Drug Reviews, 1991
• Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acid
  Biochemistry, 1984
• Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion
  Biochemical and Biophysical Research Communications, 1981
• Thrombin inhibitors. 2. Amide derivatives of N.alpha.-substituted L-arginine
  Journal of Medicinal Chemistry, 1980